KATHERINE WAGNER: Open Payments
NPI 1972345072 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,166 in 248 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,540 · 2025 $6,166
Food & beverage: $6,154Education: $12
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 32 | $1,005 |
| ABBVIE INC. | 23 | $540 |
| Organon LLC | 21 | $506 |
| Regeneron Healthcare Solutions, Inc. | 15 | $500 |
| Galderma Laboratories, L.P. | 23 | $397 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $376 |
| Incyte Corporation | 23 | $352 |
| UCB, Inc. | 11 | $340 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 15 | $336 |
| PFIZER INC. | 17 | $323 |
Products named: DUPIXENT, ADBRY, ANZUPGO, SKYRIZI, OPZELURA, NEMLUVIO, Bimzelx, CIBINQO.
Industry payments across VA — which companies pay providers there.
